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Abstract
Obesity often clusters with other major cardiovascular disease risk factors, yet a subset of the
obese appears to be protected from these risks. Two obesity phenotypes are described, 1)
“metabolically healthy” obese, broadly defined as body mass index (BMI) ≥ 30 kg/m2 and
favorable levels of blood pressure, lipids, and glucose; and 2) “at risk” obese, BMI ≥ 30 with
unfavorable levels of these risk factors. More than 30% of obese American adults are
metabolically healthy. Diet and activity determinants of obesity phenotypes are unclear. We
hypothesized that metabolically healthy obese have more favorable behavioral factors, including
less adverse diet composition and higher activity levels than at risk obese in the multi-ethnic group
of 775 obese American adults ages 40–59 years from the International Population Study on
Macro/Micronutrients and Blood Pressure (INTERMAP) cohort. In gender stratified analyses,
mean values for diet composition and activity behavior variables, adjusted for age, race, and
education, were compared between metabolically healthy and at risk obese. Nearly 1 in 5
(149/775, or 19%) of obese American INTERMAP participants were classified as metabolically
healthy obese. Diet composition and most activity behaviors were similar between obesity
phenotypes, although metabolically healthy obese women reported higher sleep duration than at
risk obese women. These results do not support hypotheses that diet composition and/or physical
activity account for the absence of cardiometabolic abnormalities in metabolically healthy obese.
INTRODUCTION
Obesity is associated with higher mortality risks, higher health care costs, impaired physical
functioning, lower quality of life, and higher morbidity from major cardiovascular and
noncardiovascular causes.1–6 Obesity often clusters with other major cardiovascular disease
(CVD) risk factors including prehypertension and hypertension, dyslipidemia, and impaired
glucose tolerance7, 8, yet a subset of the obese appears to be protected from these risks. Two
obesity phenotypes have been described, 1) “metabolically healthy” obese and 2) “at risk”
obese9–11. The metabolically healthy obese phenotype is broadly defined as body mass
index (BMI) ≥ 30 kg/m2 and favorable levels of blood pressure, lipids, and glucose.
According to data from the 1994–2004 National Health and Nutrition Examination Survey
(NHANES)12, more than 30% of the nearly 61 million obese American adults are
metabolically healthy obese, defined as obese with no more than one cardiometabolic risk
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factor. With metabolically healthy defined as no adverse levels of cardiometabolic risk
factors, 17 % of obese are metabolically healthy.
Determinants of obesity phenotypes are unclear, particularly role of diet composition, i.e.,
intake measured either by food groups (food-based categories) or nutrients (macro-/
micronutrients); and behaviors related to activity levels, i.e., sleep duration, television
viewing time, other sedentary behavior, and physical activity13. To our knowledge, there are
no population-based data on diet composition by obesity phenotype; aside from leisure time
activity, behaviors related to activity levels have rarely been assessed in obesity phenotypes.
Furthermore, obese phenotypes have rarely been investigated in ethnically diverse groups,
including those with inordinately high prevalence rates of obesity and CVD risk factors.
Here we present data on these matters for a multi-ethnic cohort of 2,195 adults ages 40–59
years from eight diverse U.S. population samples of the INTERMAP Study14–16. We
hypothesized that metabolically healthy obese have more favorable behavioral factors,
including less adverse diet composition and higher physical activity levels than at risk obese.
METHODS AND PROCEDURES
Participants
The International Population Study on Macro/Micronutrients and Blood Pressure
(INTERMAP) is a cross-sectional investigation of the relation of dietary factors (foods/
nutrients) and urinary metabolites to blood pressure14, 16, 17. It includes 4,680 men and
women ages 40–59 from 17 diverse population samples, including 2,195 persons from eight
diverse American population samples. Details about eligibility criteria and baseline
demographic characteristics have been published16. Each sample was selected randomly
from an age/gender stratified population list, to give approximately equal numbers of people
in each of four 10-year age-gender groups (men ages 40–49 and 50–59; women ages 40–49
and 50–59).
This study is based on 2,195 participants from US samples. Of these, non-obese persons
(BMI < 30 kg/m2) were excluded, leaving a total of 775 obese American adults (398 men
and 377 women), i.e., 35% of the American INTERMAP cohort, for analysis.
Data collection
Each participant attended the local INTERMAP research center on four occasions: two visits
on consecutive days with a further two visits on consecutive days on average three weeks
later. Whenever possible, one visit by each participant included a weekend day (or an
equivalent rest day) according to work schedule. All data were collected by trained and
certified staff using high quality standardized methods. The protocol was approved by the
institutional review board at each research center and written consent was obtained from
each participant.
Blood pressure and other data—Blood pressure of the seated participant was
measured twice per visit (four different days) with a random zero sphygmomanometer after
emptying the bladder and at least five minutes of rest in a quiet room. Pulse was measured
three times per visit. At the first and third visit, height without shoes was measured using a
vertically placed rule with the base at floor level and weight was measured using a balance
beam or weighing scale. BMI was calculated as weight divided by height squared (kg/m2).
Data on demographic and other factors, including education, sleep duration, television
viewing time, leisure-time and work-related physical activity (usual hours per day spent
sitting or doing light and moderate/heavy activity) smoking (current, former, or never
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smoker), family and previous medical history, current special diet, and medication use were
collected by interviewer-administered questionnaire.
Dietary data—Dietary data were collected at each of the four visits by a trained certified
interviewer using the in-depth multipass 24-hour recall method. All foods and beverages
consumed in the previous 24 hours were recorded. To aid accurate recall, fresh foods of
varied standardized portion sizes, food and drink models, containers of various types and
sizes, and photographs were used. Interviewers used neutral probing techniques to check for
completeness of items reported, and details such as brand names of foods, quantities,
processing methods, additions in cooking and/or at table, and amounts left on plate15, 16.
Dietary information was directly computerized with use of a program to guide on-screen
coding. Nutrient intakes of participants were calculated from U.S. specific food tables. Daily
alcohol consumption (amount and type of alcoholic beverage) over the previous seven days
and, for abstainers, information on previous drinking were obtained by interview twice, at
the first and third visits; these data were in addition to those on alcohol intake from the four
24-hour dietary recalls. Abstainers were those who reported no current alcohol consumption
in the four dietary recalls, all others were considered current drinkers. 83 nutrient variables,
including total energy intake and macro-/micronutrients were assessed. Food group analyses
were performed using the Nutrition Data System for Research (NDSR) version 2.91from the
Nutrition Coordinating Center (NCC) at the University of Minnesota18. The NDSR includes
9 generic food groups and 168 subgroups that were considered in these analyses. Based on
NDSR groupings, INTERMAP investigators created 16 food groups and 42 food-based
subgroups, concentrating on specific food subgroups including meat and fish, dairy, eggs,
fruits, vegetables, and grains. The 34 nutrient variables and 14 food group variables selected
for this analysis were those putatively associated with healthy diet composition. The food
group variables are described in Appendix A. Both individual nutrient and food group
variables were analyzed in regard to the outcomes of interest. 19, 20
Urinary data—For the optimal assessment of dietary sodium, potassium, and total protein
intake, two timed 24-hour urine specimens were collected; urinary sodium (Na), potassium
(K), creatinine, urea (index of 24-hour total protein intake), and multiple other metabolites
were measured16. Timed collections were started at the research center on the first and third
visits, and completed at the center the following day. Urine aliquots were stored frozen at
−20°C before being shipped frozen to a Central Laboratory in Leuven, Belgium, where
analyses were performed with extensive internal and external quality control; further
analyses were subsequently done at a Central Laboratory in London, England. Individual
excretion values were calculated as the product of concentrations in the urine and urinary
volume corrected to 24 hours. The average of the two excretion values was used.
Definition of obesity phenotypes
Since there are no uniform criteria to define obese phenotypes, an INTERMAP specific
definition was developed. Metabolically healthy was defined as meeting all of the following
criteria: favorable blood pressure (≤120/≤80 mm Hg) and no medication or special diet for
hypertension; no physician diagnosis, medication, or special diet for other metabolic risk
factors (i.e., diabetes and dyslipidemia); no prevalent cardiovascular disease. Any
participant not meeting these criteria was classified as at risk obese.
Statistical analyses
Prevalence rates of metabolically healthy obese and at risk obese were calculated separately
for the two genders and for the whole sample. Overall mean values for continuous
descriptive variables (age, years of education, BMI, pulse) and proportions of categorical
descriptive variables (% female, % nonWhite, % current drinkers, % current smokers, %
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with family history of hypertension) were calculated for metabolically healthy and at risk
obese. Differences in overall mean values between the metabolically healthy and at risk
obese were compared using t-tests; proportions were compared using chi-square analyses.
All other analyses were done separately within gender groups. Means, adjusted for age, race,
and education, were calculated for 14 food groups, 34 macro-/micronutrients, and 5 activity
behavior variables. Data for food group variables were not normally distributed; adjusted
means of log-transformed food group values were calculated and back transformed for
presentation as geometric means. T-tests were used to compare adjusted means of
metabolically healthy and at risk obese by gender. To address potential type I error from
multiple comparisons of the 53 food group, nutrient, and activity variables, Bonferroni
correction was performed; the corrected α level for significant results was 0.05/53=0.001. In
a sensitivity analysis, all of the aforementioned analyses were repeated with the criteria for
healthy obese also including nonsmoking. Analyses were done by the first author (A.
Hankinson) with SAS statistical software, version 9.2 (SAS Inc, Cary, NC).
RESULTS
Prevalence and characteristics of obese phenotypes
Descriptive statistics for 775 obese American INTERMAP participants, stratified by gender,
are shown in Table 1; 19% (149/775) met the definition of metabolically healthy obese.
Prevalence of metabolically healthy obese was similar in men and women (20% and 19%,
respectively). Compared with at risk obese, metabolically healthy obese adults were
significantly younger; there were the following nonsignificant differences: lower BMI,
higher proportion of nonWhite race/ethnicity (Black, Hispanic, Asian, and Native
American), and lower prevalence of family history of hypertension. In sensitivity analysis
with no smoking as an additional criterion for metabolically healthy obese, 127 of the 775
participants (16%) met all criteria; the remaining 648 were considered at risk obese. Results
(not tabulated here) were nearly identical to the overall results.
Diet composition: Food groups and macro-/micronutrients
Fourteen food groups and 34 dietary macro-/micronutrients were compared between at risk
and metabolically healthy obese phenotypes. There were no significant differences in food
groups (Table 2) or nutrients (Table 3) between obesity phenotypes. In both genders,
metabolically healthy obese reported nonsignificantly lower energy intake compared with at
risk obese. There was no significant difference in type or amount of food group intake,
including fruits and vegetables, grains, meats, fish, and sugar sweetened beverages across
obesity phenotypes. In women, the metabolically healthy obese reported higher amounts of
vegetable protein and starch and lower amounts of total protein (estimated from urinary
urea) compared with at risk obese. These differences had p-values below 0.05, but did not
meet the alpha level of significance adjusted for multiple comparisons. Intakes of other
macro-/micronutrients, including total fat, protein, carbohydrate, fiber, iron, and alcohol
were similar across the two obesity phenotypes for men and women.
Activity behaviors: Sleep, television viewing time, other sedentary activity, physical
activity levels
There were no significant differences in sleep duration, television viewing time, other
sedentary activity, and physical activity levels between obesity phenotypes in men (Table 4).
In women, metabolically healthy obese reported significantly higher sleep duration than at
risk obese (7.6 hours/day vs. 7.0 hours/day); there were no significant differences in other
activity behaviors.
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DISCUSSION
In this population-based study of 775 obese American middle-aged adults, 19% (nearly 1 in
5) met criteria for metabolically healthy obese, defined by favorable levels of
cardiometabolic risk factors. This study is the first, to our knowledge, to compare diet
composition between obesity phenotypes. Diet composition, measured as intake of food
groups and macro-/micronutrients, and activity behaviors (e.g., television viewing time,
other sedentary activity, and physical activity levels) were similar between obesity
phenotypes, with the exception of longer sleep duration in metabolically healthy obese
women. Other factors, including BMI, energy intake, and sociodemographic characteristics
were similar between obesity phenotypes. These results prevailed with no smoking as an
additional criterion for metabolically healthy obese. Our results indicate that diet
composition and activity behaviors do not explain the absence of cardiometabolic
abnormalities in metabolically healthy obese adults.
The 19% prevalence rate for the metabolically healthy obese phenotype observed in the
present study is lower than the 23–32% reported in previous studies.11, 12, 21 Our lower
prevalence rate may be explained by our more strict definition for the metabolically healthy
obese phenotype, particularly our criteria for favorable blood pressure (≤ 120/80 mm Hg and
no antihypertensive medications). Other studies with blood pressure in the definition of
metabolically healthy obesity used a threshold of 140/90 or 130/85 mmHg, i.e., inclusive of
persons with prehypertension22 in the metabolically healthy obese group. Also, some
definitions included one cardiometabolic abnormality in the definition of the metabolically
healthy obese phenotype. A recent NHANES report estimated the prevalence of
metabolically healthy American obese to be 32% based on a definition including one
cardiometabolic abnormality; prevalence was 17% when metabolically healthy was defined
as absence of any cardiometabolic abnormalities, i.e., a rate similar to ours. 12
No significant associations were observed between obesity phenotypes and diet
composition. This absence of significant association between diet composition and obesity
phenotypes is relevant in the light of compelling observational study and clinical trial
evidence that a healthy diet may be associated with the metabolically healthy obese
phenotype regardless of diet quantity (energy intake). For example, in overweight/obese
adults, the Diabetes Control and Complications Trial and the Finnish Diabetes Prevention
Study both reported a 58% reduction in incident diabetes through diet and activity
interventions with modest (<10%) weight loss.23, 24 The OmniHeart trial demonstrated
beneficial effects on blood pressure, high density lipoprotein cholesterol (HDL-C), and
triglycerides with isocaloric replacement of carbohydrates by proteins or unsaturated fat in
adults with mean BMI of 30.2 kg/m2.25 INTERMAP and other observational studies have
shown similar associations between diet composition and CVD risk factor levels. In
particular, prior work in the INTERMAP cohort has demonstrated an inverse relationship to
blood pressure of several macro-/micronutrients, including calcium, magnesium,
phosphorous, total and non heme iron, vegetable protein, and omega-3 fatty acids.26–31 Of
these nutrients, in the present study only vegetable protein was noted to be higher in the
metabolically healthy obese; the finding prevailed only in women and the p-value was not
statistically significant after adjustment for multiple comparisons.
While no study, to our knowledge, has reported sleep duration or sedentary behaviors in
obesity phenotypes, a few cross-sectional studies have investigated associations between
physical activity levels and obesity phenotypes, with contradictory results. Self-reported
activity data showed associations between higher activity and the metabolically healthy
obesity phenotype, while objective physical activity data did not.12, 32 Results of the current
study for activity levels are concordant with objective physical activity data. Among obese
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women, the metabolically healthy reported 0.6 hours longer sleep duration than at risk
obese. Although shorter sleep duration has often been associated with obesity in cross-
sectional and prospective studies,33, 34 this is the first report of an association with the at risk
obesity phenotype. It is hypothesized that shorter sleep duration and obesity may be linked
through neuroendocrine changes that influence appetite and favor a positive caloric
balance,34 or through behaviors often correlated with short sleep duration, such as television
viewing time and consumption of high energy foods.35, 36 These hypotheses are not likely to
explain the observed association with obesity phenotypes in our cohort of American
INTERMAP women, since energy intake, television viewing time, and diet composition
were similar in at risk and metabolically healthy obese women. While measures of sedentary
behavior were not statistically different between obesity phenotypes, metabolically healthy
obese men reported fewer hours of television viewing time and metabolically healthy obese
women reported less sedentary activity than their at risk obese counterparts, suggesting less
sedentary behavior in the metabolically healthy obese compared with at risk obese.
Mean age of metabolically healthy obese was nearly three years younger than the at risk
obese, consistent with findings from NHANES.12 Other studies comparing mean age
between obesity phenotypes reported discrepant findings, showing significantly older age of
healthy obese,12, 37 or no significant difference in age.38–41
Our study has several strengths, including our strict definition of metabolically healthy
obese and the high quality diet data, meticulously measured with four separate in-depth
multi pass 24-hour recalls. We also recorded several measures of activity behavior,
including sleep duration, two measures of sedentary behavior, and physical activity levels of
varying intensities (light and moderate to vigorous). We corrected for multiple testing using
a conservative method to adjust the alpha level, which likely inflated type II (false negative)
error. Our study is limited by its cross sectional design, which precludes assessment of
relationships between antecedent behavioral factors and obesity phenotypes. Another
limitation needing emphasis is the absence of INTERMAP data on blood glucose and lipids
for our obesity phenotype classification. Finally, although diet data was collected with rigor,
recall bias of dietary data is likely.
In conclusion, nearly 1 in 5 (19%) of obese INTERMAP middle-aged American adult
participants were classified as metabolically healthy, a prevalence rate similar to that of
previous reports using similar definitions. Diet composition, measured by food group and
macro-/micronutrient intake, was not associated with obesity phenotype. While sleep
duration was associated with obesity phenotype in women, other activity behaviors factors,
including television viewing time, other sedentary activity, and physical activity levels were
not significantly related to obesity phenotype. These results do not support hypotheses that
diet composition and physical activity account for absence of cardiometabolic abnormalities
in metabolically healthy obese adults.
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Table 1
Descriptive statistics of at risk and metabolically healthy obese American adults, by gender – mean (standard
deviation) or % (n)
Men (n=398) Women (n=377)
Variable At risk (n=323) Metabolically healthy (n=75) At risk (n=303) Metabolically healthy (n=74)
Age, years* 49.1 (5.3) 48.2 (4.9) 50.1 (5.3) 46.0 (4.8)
% non White, (n) 45.8 (148) 44.0 (33) 54.8 (166) 63.5 (47)
Education, years 14.7 (2.8) 15.1 (2.8) 13.7 (2.8) 13.6 (2.9)
Weight, kg 106.6 (16.4) 103.2 (13.2) 95.5 (16.3) 90.1 (12.3)
Height, meters 1.8 (0.1) 1.8 (0.1) 1.6 (0.1) 1.6 (0.1)
Body mass index, kg/m2 34.6 (4.4) 33.1 (3.3) 36.4 (5.4) 35.0 (4.4)
Pulse, beats/minute 75.4 (10.2) 72.0 (9.6) 75.7 (9.7) 76.4 (7.6)
Systolic blood pressure, mmHg* 126.7 (11.6) 112.2 (5.0) 126.2 (13.5) 109.7 (6.2)
Diastolic blood pressure, mmHg* 79.5 (10.3) 72.0 (4.7) 75.0 (8.7) 67.6 (6.2)
% Current drinkers, (n) 73.1 (236) 81.3 (61) 57.4 (174) 58.1 (43)
% Current smokers, (n) 16.1 (52) 13.3 (10) 13.9 (42) 16.2 (12)
% with family history of HTN, (n) 68.1 (220) 57.3 (43) 76.6 (232) 68.9 (51)
Abbreviations - HTN: hypertension
Metabolically healthy obese defined as BMI ≥ 30 kg/m2 and meeting all of the following criteria: blood pressure ≤120/≤80 mm Hg, no medication
or special diet for hypertension, no physician diagnosis, medication, or special diet for cardiovascular disease (CVD) risk factors (i.e., diabetes and
dyslipidemia),no prevalent CVD, and no special diet for weight loss or weight gain. Serum glucose and lipids were not measured.
*Values significantly different for at risk obese compared to metabolically healthy obese (p-value <0.05) p-values calculated using t-test for means,
chi-square test for proportions
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Appendix A
14 food group variables, adapted from Nutrition Data System for Research, Nutrition Coordinating Center
University of Minnesota
Food Groups and Subgroups Description
Total fruits 100% fruit juices and drinks, sweetened and unsweetened fruits, dried fruits
Fresh fruits Subgroup of total fruits
Total vegetables Raw, cooked (fresh, frozen, or canned), vegetarian meat substitutes, vegetable recipes
Total grains Breads, rolls, biscuits, pancakes, ready to eat cereals, grains and flour
Nuts, nut butters, and legumes Nuts, nut butters, mature dried beans and peas
Low fat dairy products Less than 2% fat content dairy products-i.e., cream, cheese, ice creams, milk/cheese recipes, milk, yogurt,
yogurt frozen, cocoa
Higher fat dairy products 2% or more fat content dairy products (listed above)
Fish and seafood Fish and fish roe, shellfish
Poultry Domestic and wild fowl
Fresh meats Beef, lamb, pork, veal, game
Processed meats Fresh and cured cold cuts, sausage
Fats Animal fats, margarines, table spreads, oils, shortening, salad dressing
Sweets Sugar, syrup, honey, jam, jelly, preserves, sweet sauces, candy
Sugar sweetened beverages Sweetened non-carbonated drinks (<100% juice), does not include artificially sweetened drinks
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